Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.11236/jph.66.1_15 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Real-world utility of ChatGPT in pre-vasectomy counselling, a safe and efficient practice: a prospective single-centre clinical study.
World J Urol
December 2024
Section of Urology, Department of Surgery, University of Manitoba, AD203-720 McDermot Avenue, Winnipeg, Manitoba, R3N 1B1, Canada.
Purpose: This study sought to assess if pre-vasectomy counselling with ChatGPT can safely streamline the consultation process by reducing visit times and increasing patient satisfaction.
Methods: A single-institution randomized pilot study was conducted to evaluate the safety and efficacy of ChatGPT for pre-vasectomy counselling. All adult patients interested in undergoing a vasectomy were included.
Willingness to Pay for Antiretroviral Drugs Covered by Medical Insurance among People Living with HIV in 18 Chinese Cities.
Biomed Environ Sci
November 2024
National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Objective: Antiretroviral drugs covered by medical insurance have been gradually used by people living with human immunodeficiency virus (PLWH) in recent years in China. This study aimed to analyze their willingness to pay (WTP) for antiretroviral drugs.
Methods: A mixed-methods study design involving a cross-sectional survey and in-depth interviews was conducted.
Willingness to Switch to Long-Acting Injectable Cabotegravir and Rilpivirine Every 2 Months for People Living with HIV in Nanjing, China.
AIDS Res Hum Retroviruses
December 2024
Department of Infectious Disease, The School of Public Health of Nanjing Medical University, The Second Hospital of Nanjing, Nanjing, China.
Daily oral medication is currently the most common antiretroviral therapy (ART) for people living with human immunodeficiency virus (PLWH). As the first complete long-acting (LA) ART regimen, cabotegravir (CAB) and rilpivirine (RPV), offer a novel treatment approach with less frequent administration, via bimonthly infusion. Due to the upcoming availability of this regimen in China, the study aimed to analyze the willingness and reasons of PLWH to switch to CAB+RPV therapy.
View Article and Find Full Text PDFWhen and why do people change their minds in favor of vaccination? Longitudinal analyses of switching COVID-19 vaccination preferences.
BMC Public Health
December 2024
National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Background: Vaccinations are a cornerstone of public health. However, reluctance to accepting vaccines is common. Using longitudinal data, we investigated which individual and contextual factors were associated with switching preferences from initial hesitancy or unwillingness toward acceptance of a first COVID-19 vaccination.
View Article and Find Full Text PDFReligious leaders' willingness to promote the uptake of human papillomavirus vaccine among their congregants in Mavoko Sub-County, Machakos County, Kenya.
Pan Afr Med J
November 2024
Department of Research and Learning, Population Services International, Parklands, Kenya.
Introduction: cervical cancer is a significant health challenge in Kenya and sub-Saharan Africa, with high mortality linked to late presentation and low awareness. Despite its prevalence, preventive interventions like human papillomavirus (HPV) vaccination face low utilization. Religious leaders play a pivotal role in influencing health decisions, yet their attitudes toward HPV vaccination remain understudied.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!